Role of connective growth factor in plasminogen activator inhibitor-1 and fibronectin expression induced by transforming growth factor β1 in renal tubular cells

Chinese Medical Journal

Volumn 117, Issue 7, 2004, Pages 990-996

  Zhang, Chun ^a   Meng, Xian Fang ^b   Zhu, Zhong Hua ^a   Yang, Xiao ^a   Deng, An Guo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antisense oligodeoxynucleotide; Connective tissue growth factor; Fibronectin; Plasminogen activator inhibitor 1; Renal tubular epithelial cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES; OLIGONUCLEOTIDES, ANTISENSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4344671694     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000;15:290-302.
2. Becker GJ, Hewitson TD, et al. The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 2000;9:133-138.
3. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20: 1-17.
4. Heidland A, Sebekova K, Paczek L, et al. Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. Kidney Int Suppl 1997;62:S32-35.
5. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-2508.
6. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
7. Roberts AB, Mccune BK, Sporn MB. TGF-β: regulation of extracellular matrix. Kidney Int 1492;41:557-559.
8. Yokoi H, Sugawara A, Mukoyama M, et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis. Am J Kidney Dis 2002;282:F933-F942.
9. Bradham DM, Igarashi A, Potter RI, et al. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114: 1285-1294.
10. Goldschmeding R, Aten J, Ito Y, et al. Connective tissue growth factor: just another factor in renal fibrosis. Nephrol Dial Transplant 2000;15:296-299.
11. Ito Y, Aten J. Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53:853-861.
12. Igarashi A, Okochi H, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993;4: 637-645.
13. Frazier K, Williams S, Grotendorst GR, et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996;107:404-411.
14. Grotendorst GR, Okochi H, Hagash N, et al. A novel transforming growth factor β response element controls the expression of connective tissue growth factor gene. Cell Growth Differ 1996;7:469-480.
15. Wang S, Denichilo M, Brubaker C, et al. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 2001;60:96-105.
16. Basile DP. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999;8:21-30.
17. Gore-Hyer E, Shegogue D, Markiewicz M, et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 2002;283: F707-F716.
18. Han DC, Hoffman BB, Hong SW, et al. Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice. Am J Physiol Renal Physiol 2000;278:F628-F634.
19. Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015-8020.
20. Wang S, Hirschberg R. BMP7 antagnized TGF-β-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 2003;284:F1006-F1013.
21. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002; 282:F933-F942.
22. Inoue T, Okada H, Kobayashi T, et al. TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme. Biochem Biophys Res Commun 2002;297:255-260.
23. Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999;13:1774-1786.
24. Inoue T, Okada H, Kobayashi T, et al. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 2003;17:268-270.
25. Eddy AA. Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 2002;283:F209-F220.
26. Badid C, Vincent M, Fouque D, et al. Myofibroblast: a prognostic marker and target cell in progressive renal disease. Renal Fail 2001;23:543-549.